STOCK TITAN

[6-K] UNILEVER PLC Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K

Unilever PLC has announced the appointment of Belén Garijo López as an independent Non-Executive Director, effective 13 May 2026. Ms. Garijo currently serves as Chair of the Executive Board and CEO of Merck Group until the end of April 2026, sits on the board of BBVA, and was a Non-Executive Director at L'Oreal from 2014 to 2024. The company highlights her global commercial experience across FMCG and healthcare and her record on diversity and transformation. The announcement complies with UK Listing Rule disclosures and provides no additional material details.

Unilever PLC ha annunciato la nomina di Belén Garijo López come Amministratore Indipendente Non-Esecutivo, con effetto 13 maggio 2026. La signora Garijo è attualmente Presidente del Consiglio Esecutivo e Amministratore Delegato del Merck Group fino alla fine di aprile 2026, fa parte del consiglio di BBVA, ed è stata Corporate Non-Esecutive Director a L'Oreal dal 2014 al 2024. L'azienda evidenzia la sua esperienza commerciale globale nei settori FMCG e sanità e il suo record su diversità e trasformazione. L'annuncio è conforme alle disposizioni delle UK Listing Rule e non fornisce ulteriori dettagli materiali.

Unilever PLC ha anunciado la designación de Belén Garijo López como Directora Independiente No Ejecutiva, con efecto a partir de 13 de mayo de 2026. La Sra. Garijo ejerció como Presidenta de la Junta Ejecutiva y CEO del Merck Group hasta finales de 2026, forma parte de la junta de BBVA, y fue Directora No Ejecutiva en L'Oreal desde 2014 hasta 2024. La empresa resalta su experiencia comercial global en FMCG y atención sanitaria y su historial en diversidad y transformación. El anuncio cumple con las divulgaciones de las Normas de Listado del Reino Unido y no proporciona detalles materiales adicionales.

Unilever PLC은 Belén Garijo López를 독립 비상임 이사로 임명했다고 발표했으며, 효과는 2026년 5월 13일부터입니다. Garijo 씨는 현재 Merck Group의 이사회 의장 겸 CEO로 2026년 4월 말까지 재임하며, BBVA 이사회에 참여하고 있으며, L'Oreal에서 2014년부터 2024년까지 비상임 이사로 재직했습니다. 회사는 FMCG 및 의료 분야에서의 글로벌 상업 경력과 다양성 및 변혁에 대한 기록을 강조합니다. 발표는 UK Listing Rule 공개 요건을 준수하며 추가 중요한 세부 정보는 제공하지 않습니다.

Unilever PLC a annoncé la nomination de Belén Garijo López en tant que Directrice Indépendante Non-Exécutive, effective à partir du 13 mai 2026. Mme Garijo est actuellement Présidente du Conseil Exécutif et CEO du Merck Group jusqu'à la fin d'avril 2026, siège au conseil de BBVA, et a été Directrice Non-Exécutive chez L'Oreal de 2014 à 2024. L'entreprise met en évidence son expérience commerciale mondiale dans les FMCG et les soins de santé et son parcours en matière de diversité et de transformation. L'annonce respecte les disclosures des règles de cotation du Royaume-Uni et ne fournit pas de détails matériels supplémentaires.

Unilever PLC hat die Ernennung von Belén Garijo López zur unabhängigen Nicht-Exekutivdirektorin mit Wirkung zum 13. Mai 2026 bekannt gegeben. Frau Garijo ist derzeit Vorsitzende des Exekutivrats und CEO der Merck Group bis Ende 2026 im April, sitzt im Vorstand von BBVA und war von 2014 bis 2024 Non-Executive Director bei L'Oreal. Das Unternehmen hebt ihre globale kommerzielle Erfahrung in FMCG und Gesundheitswesen sowie ihre Bilanz in Bezug auf Vielfalt und Transformation hervor. Die Bekanntgabe entspricht den UK Listing Rule Disclosure-Anforderungen und enthält keine weiteren wesentlichen Details.

Unilever PLC أعلنت تعيين Belén Garijo López كمديرة مستقلة غير تنفيذية، اعتبارًا من 13 مايو 2026. تعمل الآن السيدة Garijo كرئيسة مجلس الإدارة التنفيذي والرئيس التنفيذي لشركة Merck Group حتى نهاية 2026، وهي عضو في مجلس إدارة BBVA، وكانت مديرة غير تنفيذية في L'Oreal من 2014 حتى 2024. تبرز الشركة خبرتها التجارية العالمية عبر السلع الاستهلاكية والرعاية الصحية والسجل في التنوع والتحول. يتوافق الإعلان مع إفصاءات قاعدة الإدراج في المملكة المتحدة ولا يوفر تفاصيل مادية إضافية.

联合利华PLC 已宣布任命 Belén Garijo López 为独立非执行董事,生效日期为 2026年5月13日。Garijo 女士目前担任 Merck Group 执行委员会主席兼CEO,任期至 2026年4月结束,在 BBVA 任董事会成员,并且在 L'Oreal自2014年起至2024年任独立非执行董事。公司强调她在快速消费品与医疗保健领域的全球商业经验,以及她在多样性与转型方面的业绩记录。该公告符合英国上市规则披露要求,不提供其他重大细节。

Positive
  • Experienced director added: appointment of Belén Garijo López brings global commercial and healthcare leadership experience.
  • Board strengthening: adds diversity and transformation expertise relevant to FMCG and complex reorganizations.
  • Clear timing: effective date set as 13 May 2026, with current executive role ending in April 2026.
Negative
  • None.

Insights

Adding a senior, cross-sector leader strengthens board expertise ahead of 2026 transitions.

Bringing Belén Garijo López onto the board adds executive experience from large healthcare and consumer companies, which can support oversight of strategy and complex transformations. Her recent roles at Merck Group, BBVA, and prior Non-Executive service at L'Oreal indicate familiarity with global governance and regulatory environments.

The main dependencies are timing and availability after her executive role ends in April 2026, and how her responsibilities align with existing board committee assignments. Watch board committee placements and any updated disclosures around director independence following 13 May 2026.

Unilever PLC ha annunciato la nomina di Belén Garijo López come Amministratore Indipendente Non-Esecutivo, con effetto 13 maggio 2026. La signora Garijo è attualmente Presidente del Consiglio Esecutivo e Amministratore Delegato del Merck Group fino alla fine di aprile 2026, fa parte del consiglio di BBVA, ed è stata Corporate Non-Esecutive Director a L'Oreal dal 2014 al 2024. L'azienda evidenzia la sua esperienza commerciale globale nei settori FMCG e sanità e il suo record su diversità e trasformazione. L'annuncio è conforme alle disposizioni delle UK Listing Rule e non fornisce ulteriori dettagli materiali.

Unilever PLC ha anunciado la designación de Belén Garijo López como Directora Independiente No Ejecutiva, con efecto a partir de 13 de mayo de 2026. La Sra. Garijo ejerció como Presidenta de la Junta Ejecutiva y CEO del Merck Group hasta finales de 2026, forma parte de la junta de BBVA, y fue Directora No Ejecutiva en L'Oreal desde 2014 hasta 2024. La empresa resalta su experiencia comercial global en FMCG y atención sanitaria y su historial en diversidad y transformación. El anuncio cumple con las divulgaciones de las Normas de Listado del Reino Unido y no proporciona detalles materiales adicionales.

Unilever PLC은 Belén Garijo López를 독립 비상임 이사로 임명했다고 발표했으며, 효과는 2026년 5월 13일부터입니다. Garijo 씨는 현재 Merck Group의 이사회 의장 겸 CEO로 2026년 4월 말까지 재임하며, BBVA 이사회에 참여하고 있으며, L'Oreal에서 2014년부터 2024년까지 비상임 이사로 재직했습니다. 회사는 FMCG 및 의료 분야에서의 글로벌 상업 경력과 다양성 및 변혁에 대한 기록을 강조합니다. 발표는 UK Listing Rule 공개 요건을 준수하며 추가 중요한 세부 정보는 제공하지 않습니다.

Unilever PLC a annoncé la nomination de Belén Garijo López en tant que Directrice Indépendante Non-Exécutive, effective à partir du 13 mai 2026. Mme Garijo est actuellement Présidente du Conseil Exécutif et CEO du Merck Group jusqu'à la fin d'avril 2026, siège au conseil de BBVA, et a été Directrice Non-Exécutive chez L'Oreal de 2014 à 2024. L'entreprise met en évidence son expérience commerciale mondiale dans les FMCG et les soins de santé et son parcours en matière de diversité et de transformation. L'annonce respecte les disclosures des règles de cotation du Royaume-Uni et ne fournit pas de détails matériels supplémentaires.

Unilever PLC hat die Ernennung von Belén Garijo López zur unabhängigen Nicht-Exekutivdirektorin mit Wirkung zum 13. Mai 2026 bekannt gegeben. Frau Garijo ist derzeit Vorsitzende des Exekutivrats und CEO der Merck Group bis Ende 2026 im April, sitzt im Vorstand von BBVA und war von 2014 bis 2024 Non-Executive Director bei L'Oreal. Das Unternehmen hebt ihre globale kommerzielle Erfahrung in FMCG und Gesundheitswesen sowie ihre Bilanz in Bezug auf Vielfalt und Transformation hervor. Die Bekanntgabe entspricht den UK Listing Rule Disclosure-Anforderungen und enthält keine weiteren wesentlichen Details.

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_________________________________________________
FORM 6-K
_________________________________________________
 
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
OF THE SECURITIES EXCHANGE ACT OF 1934
 
October 2025
Commission File
Number: 001-04546
______________________________________________________
 UNILEVER PLC
(Translation of registrant’s name into English)
 _____________________________________________________
 
UNILEVER HOUSE, BLACKFRIARS, LONDON, ENGLAND
(Address of principal executive office)
_____________________________________________________
Indicate by check mark whether the registrant files or will file annual reports
under cover of Form 20-F or Form 40-F.
Form 20-F ☒       Form 40-F ☐
 
 
 Unilever PLC
Appointment of NED
  
Unilever PLC today announced that Belén Garijo López has been appointed as an independent Non-Executive Director. Belén will join the Unilever Board with effect from 13 May 2026.
  
Belén also serves on the board of Banco Bilbao Vizcaya Argentaria (BBVA) and previously served as Non-Executive Director for L'Oreal from 2014 to 2024. She is serving as Chair of the Executive Board and Chief Executive Officer of Merck Group until the end of April 2026.
 
Belén brings extensive global commercial expertise across the FMCG and healthcare sectors, with a proven track record of driving performance and leading complex transformations. She is widely recognised for her leadership in diversity and international collaboration.
 
Ian Meakins, Chair of Unilever PLC, said: "I am very pleased that Belén has agreed to join the Board. She has had an extremely successful executive career, most recently in the healthcare sector, and has extensive experience leading large and well-respected organisations. Belén will further strengthen the Board with her expertise and we look forward to working together."
 
This announcement is made in accordance with UK Listing Rule 6.4.6R. There are no further details required to be disclosed by UK Listing Rule 6.4.8R.
  
-End-
 
For further information, please contact:
  
Investor Relations: Investor.Relations@unilever.com
Unilever Press Office: Press-Office.London@unilever.com
  
Cautionary Statement
  
This announcement may contain forward-looking statements, including 'forward-looking statements' within the meaning of the United States Private Securities Litigation Reform Act of 1995, of the Unilever Group (the "Group"). All statements other than statements of historical fact are, or may deemed to be, forward-looking statements. Words such as 'will', 'aim', 'expects', 'anticipates', 'intends', 'looks', 'believes', 'vision', 'ambition', 'target', 'goal', 'plan', 'potential', 'work towards', 'may', 'milestone', 'objectives', 'outlook', 'probably', 'project', 'risk', 'seek', 'continue', 'projected', 'estimate', 'achieve' or the negative of these terms, and other similar expressions of future performance or results and their negatives, are intended to identify such forward-looking statements. Forward-looking statements can also include, but are not limited to, statements and information regarding the Group's emissions reduction and other sustainability-related targets and other climate and sustainability matters (including actions, potential impacts and risks and opportunities associated therewith). Forward-looking statements can be made in writing but also may be made verbally by directors, officers and employees of the Group in connection with this announcement. These forward-looking statements are based upon current expectations and assumptions regarding anticipated developments and other factors affecting the Group. They are not historical facts, nor are they guarantees of future performance or outcomes. All forward-looking statements contained in this announcement are expressly qualified in their entirety by the cautionary statements contained or referred to in this section. Readers should not place undue reliance on forward-looking statements.
  
Because these forward-looking statements involve known and unknown risks and uncertainties, a number of which may be beyond the Group's control, there are important factors that could cause actual results to differ materially from those expressed or implied by these forward-looking statements.
  
The forward-looking statements are based on our beliefs, assumptions and expectations of our future performance, taking into account all information currently available to us. Forward-looking statements are not predictions of future events. These beliefs, assumptions and expectations can change as a result of many possible events or factors, not all of which are known to us. If a change occurs, our business, financial condition, liquidity and results of operations may vary materially from those expressed in our forward-looking statements.
 
The forward-looking statements speak only as of the date of this announcement. Except as required by any applicable law or regulation, the Group expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Group's expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based. New risks and uncertainties arise over time, and it is not possible for us to predict those events or how they may affect us. In addition, we cannot assess the impact of each factor on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements.
 
Further details of potential risks and uncertainties affecting the Group are described in the Group's filings with the London Stock Exchange, Euronext Amsterdam, and the US Securities and Exchange Commission, including in the Annual Report on Form 20-F 2024. The Annual Report on Form 20-F 2024 is separately filed with the US Securities and Exchange Commission and both the Annual Report on Form 20-F 2024 and the Unilever Annual Report and Accounts 2024 are available on our corporate website: www.unilever.com.
 
 
 
 
Signatures
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
UNILEVER PLC
 
/S/ M VARSELLONA
 
 
 
By M VARSELLONA
 
CHIEF LEGAL OFFICER AND GROUP SECRETARY
 
 
 
 
 
 
 
Date 07 October 2025

FAQ

What change did Unilever (UL) announce in this Form 6-K?

Unilever announced the appointment of Belén Garijo López as an independent Non-Executive Director effective 13 May 2026.

What roles does Belén Garijo López currently hold?

She is serving as Chair of the Executive Board and CEO of Merck Group until the end of April 2026 and is a board member of BBVA.

Did Unilever disclose any committee assignments or additional details?

No. The announcement states there are no further details required under the referenced UK Listing Rules.

Was the appointment linked to any major transaction or financial metric?

No. The filing only announces the director appointment and provides background on her experience; no transactions or financial figures were disclosed.

Where can investors find more risk disclosures referenced in the filing?

The filing refers readers to the Group's Annual Report on Form 20-F 2024 and corporate website at www.unilever.com for further risks and disclosures.
Unilever

NYSE:UL

UL Rankings

UL Latest News

UL Latest SEC Filings

UL Stock Data

143.70B
2.45B
0%
9.54%
0.14%
Household & Personal Products
Consumer Defensive
Link
United Kingdom
London